Next Article in Journal
Digital Light Processing Bioprinted Human Chondrocyte-Laden Poly (γ-Glutamic Acid)/Hyaluronic Acid Bio-Ink towards Cartilage Tissue Engineering
Next Article in Special Issue
Small Extracellular Vesicle Enrichment of a Retrotransposon-Derived Double-Stranded RNA: A Means to Avoid Autoinflammation?
Previous Article in Journal
Therapeutic Effects of the Addition of Fibroblast Growth Factor-2 to Biodegradable Gelatin/Magnesium-Doped Calcium Silicate Hybrid 3D-Printed Scaffold with Enhanced Osteogenic Capabilities for Critical Bone Defect Restoration
Previous Article in Special Issue
Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease
Review

Extracellular Vesicles in Innate Immune Cell Programming

1
Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
2
Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK
*
Author to whom correspondence should be addressed.
Academic Editors: Andreas Spittler, Wolfgang Holnthoner and Viktoria Weber
Biomedicines 2021, 9(7), 713; https://doi.org/10.3390/biomedicines9070713
Received: 13 May 2021 / Revised: 10 June 2021 / Accepted: 14 June 2021 / Published: 23 June 2021
(This article belongs to the Special Issue Extracellular Vesicles in Inflammation)
Extracellular vesicles (EV) are a heterogeneous group of bilipid-enclosed envelopes that carry proteins, metabolites, RNA, DNA and lipids from their parent cell of origin. They mediate cellular communication to other cells in local tissue microenvironments and across organ systems. EV size, number and their biologically active cargo are often altered in response to pathological processes, including infection, cancer, cardiovascular diseases and in response to metabolic perturbations such as obesity and diabetes, which also have a strong inflammatory component. Here, we discuss the broad repertoire of EV produced by neutrophils, monocytes, macrophages, their precursor hematopoietic stem cells and discuss their effects on the innate immune system. We seek to understand the immunomodulatory properties of EV in cellular programming, which impacts innate immune cell differentiation and function. We further explore the possibilities of using EV as immune targeting vectors, for the modulation of the innate immune response, e.g., for tissue preservation during sterile injury such as myocardial infarction or to promote tissue resolution of inflammation and potentially tissue regeneration and repair. View Full-Text
Keywords: exosomes; transcription; neutrophil; monocyte; hematopoietic stem cell exosomes; transcription; neutrophil; monocyte; hematopoietic stem cell
Show Figures

Figure 1

MDPI and ACS Style

Akbar, N.; Paget, D.; Choudhury, R.P. Extracellular Vesicles in Innate Immune Cell Programming. Biomedicines 2021, 9, 713. https://doi.org/10.3390/biomedicines9070713

AMA Style

Akbar N, Paget D, Choudhury RP. Extracellular Vesicles in Innate Immune Cell Programming. Biomedicines. 2021; 9(7):713. https://doi.org/10.3390/biomedicines9070713

Chicago/Turabian Style

Akbar, Naveed, Daan Paget, and Robin P. Choudhury. 2021. "Extracellular Vesicles in Innate Immune Cell Programming" Biomedicines 9, no. 7: 713. https://doi.org/10.3390/biomedicines9070713

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop